264 related articles for article (PubMed ID: 19295505)
1. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.
Hebert MF; Ma X; Naraharisetti SB; Krudys KM; Umans JG; Hankins GD; Caritis SN; Miodovnik M; Mattison DR; Unadkat JD; Kelly EJ; Blough D; Cobelli C; Ahmed MS; Snodgrass WR; Carr DB; Easterling TR; Vicini P;
Clin Pharmacol Ther; 2009 Jun; 85(6):607-14. PubMed ID: 19295505
[TBL] [Abstract][Full Text] [Related]
2. Effects of Pregnancy on the Pharmacokinetics of Metformin.
Liao MZ; Flood Nichols SK; Ahmed M; Clark S; Hankins GD; Caritis S; Venkataramanan R; Haas D; Quinney SK; Haneline LS; Tita AT; Manuck T; Wang J; Thummel KE; Brown LM; Ren Z; Easterling TR; Hebert MF
Drug Metab Dispos; 2020 Apr; 48(4):264-271. PubMed ID: 31980499
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.
Shuster DL; Shireman LM; Ma X; Shen DD; Flood Nichols SK; Ahmed MS; Clark S; Caritis S; Venkataramanan R; Haas DM; Quinney SK; Haneline LS; Tita AT; Manuck TA; Thummel KE; Brown LM; Ren Z; Brown Z; Easterling TR; Hebert MF
Clin Pharmacol Ther; 2020 Jun; 107(6):1362-1372. PubMed ID: 31869430
[TBL] [Abstract][Full Text] [Related]
4. Is glyburide safe in pregnancy?
Kimber-Trojnar Ż; Marciniak B; Patro-Malysza J; Skorzynska-Dziduszko K; Poniedzialek-Czajkowska E; Mierzynski R; Galczynski K; Trojnar M; Leszczynska-Gorzelak B; Oleszczuk J
Curr Pharm Biotechnol; 2014; 15(1):100-12. PubMed ID: 24720590
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of Metformin in Pregnant Women With Gestational Diabetes Mellitus and Nonpregnant Women With Type 2 Diabetes Mellitus.
Shuster DL; Shireman LM; Ma X; Shen DD; Flood Nichols SK; Ahmed MS; Clark S; Caritis S; Venkataramanan R; Haas DM; Quinney SK; Haneline LS; Tita AT; Manuck TA; Thummel KE; Morris Brown L; Ren Z; Brown Z; Easterling TR; Hebert MF
J Clin Pharmacol; 2020 Apr; 60(4):540-549. PubMed ID: 31742716
[TBL] [Abstract][Full Text] [Related]
6. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.
Camelo Castillo W; Boggess K; Stürmer T; Brookhart MA; Benjamin DK; Jonsson Funk M
Obstet Gynecol; 2014 Jun; 123(6):1177-1184. PubMed ID: 24807336
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus.
Malek R; Davis SN
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):691-9. PubMed ID: 27163280
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
[TBL] [Abstract][Full Text] [Related]
9. A comparison of glyburide and insulin in women with gestational diabetes mellitus.
Langer O; Conway DL; Berkus MD; Xenakis EM; Gonzales O
N Engl J Med; 2000 Oct; 343(16):1134-8. PubMed ID: 11036118
[TBL] [Abstract][Full Text] [Related]
10. Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial.
Mirzamoradi M; Heidar Z; Faalpoor Z; Naeiji Z; Jamali R
Acta Med Iran; 2015; 53(2):97-103. PubMed ID: 25725178
[TBL] [Abstract][Full Text] [Related]
11. Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk.
Bouchghoul H; Alvarez JC; Verstuyft C; Bouyer J; Senat MV
PLoS One; 2020; 15(5):e0232002. PubMed ID: 32379777
[TBL] [Abstract][Full Text] [Related]
12. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.
Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B
Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615
[TBL] [Abstract][Full Text] [Related]
13. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
Langer O; Yogev Y; Xenakis EM; Rosenn B
Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015
[TBL] [Abstract][Full Text] [Related]
14. Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age.
Shuster DL; Risler LJ; Liang CK; Rice KM; Shen DD; Hebert MF; Thummel KE; Mao Q
J Pharmacol Exp Ther; 2014 Aug; 350(2):425-34. PubMed ID: 24898265
[TBL] [Abstract][Full Text] [Related]
15. Metformin compared with glyburide for the management of gestational diabetes.
Silva JC; Pacheco C; Bizato J; de Souza BV; Ribeiro TE; Bertini AM
Int J Gynaecol Obstet; 2010 Oct; 111(1):37-40. PubMed ID: 20542272
[TBL] [Abstract][Full Text] [Related]
16. Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes.
Palatnik A; Harrison RK; Thakkar MY; Walker RJ; Egede LE
Am J Perinatol; 2022 Jan; 39(1):8-15. PubMed ID: 34758497
[TBL] [Abstract][Full Text] [Related]
17. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
[TBL] [Abstract][Full Text] [Related]
18. Glyburide for the treatment of gestational diabetes. A critical appraisal.
Moore TR
Diabetes Care; 2007 Jul; 30 Suppl 2():S209-13. PubMed ID: 17596474
[TBL] [Abstract][Full Text] [Related]
19. CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects.
Yin OQ; Tomlinson B; Chow MS
Clin Pharmacol Ther; 2005 Oct; 78(4):370-7. PubMed ID: 16198656
[TBL] [Abstract][Full Text] [Related]
20. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.
Guo L; Ma J; Tang J; Hu D; Zhang W; Zhao X
J Diabetes Res; 2019; 2019():9804708. PubMed ID: 31781670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
